Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings

Andrew Phillips; Valentina Cambiano; Fumiyo Nakagawa; Travor Magubu; Alec Miners; Debbie Ford; Deenan Pillay; Andrea De Luca; Jens Lundgren; Paul Revill

doi:10.1371/journal.pone.0109148

Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings

Andrew Phillips, Valentina Cambiano, Fumiyo Nakagawa, Travor Magubu, Alec Miners, Debbie Ford, Deenan Pillay, Andrea De Luca, Jens Lundgren, Paul Revill

Università Cattolica del Sacro Cuore

Risultato della ricerca: Contributo in rivista › Articolo in rivista

22 Citazioni (Scopus)

Abstract

To guide future need for cheap resistance tests for use in low income settings, we assessed cost-effectiveness of drug resistance testing as part of monitoring of people on first line ART - with switching from first to second line ART being conditional on NNRTI drug resistance mutations being identified.

Lingua originale	English
pagine (da-a)	e109148-e109148
Rivista	PLoS One
Volume	9
DOI	https://doi.org/10.1371/journal.pone.0109148
Stato di pubblicazione	Pubblicato - 2014

Keywords

HIV
cost
therapy

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1371/journal.pone.0109148

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{ad1fea0b20724852a5d25c00dfa7d96f,

title = "Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings",

abstract = "To guide future need for cheap resistance tests for use in low income settings, we assessed cost-effectiveness of drug resistance testing as part of monitoring of people on first line ART - with switching from first to second line ART being conditional on NNRTI drug resistance mutations being identified.",

keywords = "HIV, cost, therapy, HIV, cost, therapy",

author = "Andrew Phillips and Valentina Cambiano and Fumiyo Nakagawa and Travor Magubu and Alec Miners and Debbie Ford and Deenan Pillay and {De Luca}, Andrea and Jens Lundgren and Paul Revill",

year = "2014",

doi = "10.1371/journal.pone.0109148",

language = "English",

volume = "9",

pages = "e109148--e109148",

journal = "PLoS One",

issn = "1932-6203",

publisher = "Public Library of Science",

}

TY - JOUR

T1 - Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings

AU - Phillips, Andrew

AU - Cambiano, Valentina

AU - Nakagawa, Fumiyo

AU - Magubu, Travor

AU - Miners, Alec

AU - Ford, Debbie

AU - Pillay, Deenan

AU - De Luca, Andrea

AU - Lundgren, Jens

AU - Revill, Paul

PY - 2014

Y1 - 2014

N2 - To guide future need for cheap resistance tests for use in low income settings, we assessed cost-effectiveness of drug resistance testing as part of monitoring of people on first line ART - with switching from first to second line ART being conditional on NNRTI drug resistance mutations being identified.

AB - To guide future need for cheap resistance tests for use in low income settings, we assessed cost-effectiveness of drug resistance testing as part of monitoring of people on first line ART - with switching from first to second line ART being conditional on NNRTI drug resistance mutations being identified.

KW - HIV

KW - cost

KW - therapy

KW - HIV

KW - cost

KW - therapy

UR - http://hdl.handle.net/10807/63937

U2 - 10.1371/journal.pone.0109148

DO - 10.1371/journal.pone.0109148

M3 - Article

SN - 1932-6203

VL - 9

SP - e109148-e109148

JO - PLoS One

JF - PLoS One

ER -

Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo